Clinical Trials Browser

Phase 3 × Interventional × Efficacy × Clear all

NCT05427305 2022-06-22

TAB008 Compared to Avastin® in Patients With EGFR Wild-type Non-squamous Non-small Cell Lung Cancer

Phase 3 Completed

Efficacy